MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Osmotic demyelination syndrome with dystonia and parkinsonism responsive to dopaminergic therapy

    L.E. Katus, S.J. Frucht (New York, NY, USA)

    Objective: To present a case of delayed-onset dystonia and parkinsonism secondary to osmotic demyelination syndrome, with dramatic response to pramipexole 3mg per day. Background: Osmotic…
  • 2016 International Congress

    Hydrogen sulfide functions as a neuromodulator to regulate striatal neurotransmission in a mouse model of Parkinson’s disease

    L. Zhang, M. Wang, J. Zhu, Y. Pan, J. Dong (Nanjing, People's Republic of China)

    Objective: To Evaluate:prepared a MPTP/p induced mouse subacute model of PD, and explore the modulatory effect of H2S on monoamine and amino acid neurotransmitters in…
  • 2016 International Congress

    Medicinal cannabis for Parkinson’s disease: A survey of practices, beliefs, and attitudes among providers at NPF centers of excellence

    D. Bega, T. Simuni, M.S. Okun, P. Schmidt (Chicago, IL, USA)

    Objective: To gather data on the cannabis-related prescribing practices, and views regarding potential risks and benefits of cannabis, among experts caring for patients with PD.…
  • 2016 International Congress

    Pisa syndrome in Parkinson’s disease: A mobile orfixed deformity?

    E.I. Giyazitdinova, B.T. Muinjonov, G.S. Rakhimbaeva, Y.A. Musaeva, F.K. Shermukhamedova (Taskent, Uzbekistan)

    Objective: To study of Pisa syndrome in Parkinson's disease. Background: Although Pisa syndrome and scoliosis are sometimes used interchangeably to describe a laterally flexed postural…
  • 2016 International Congress

    Utilization and longitudinal impact of anticholinergic use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry

    V. Felix Saunders, K. Li, S. Luo, T. Simuni (Chicago, IL, USA)

    Objective: To evaluate baseline predictors and longitudinal impact of anticholinergics use in Parkinson's disease (PD). Background: Anticholinergics have beneficial effect on tremor in PD but…
  • 2016 International Congress

    Feasibility, safety and effects of a group intervention based on European physiotherapy guideline for Parkinson´s disease

    J.E. Pompeu, T.B. Freitas, R.A. Nuvolini, K.G. Silva, F. Doná, R.A. Andreotti, N.A. Mazzini, M.G.R. Almeida, C. Torriani-Pasin (Sao Paulo, Brazil)

    Objective: To assess the feasibility, safety and effects of an group intervention based on European Physiotherapy Guideline. Background: Studies suggest that exercise may contribute to…
  • 2016 International Congress

    Pathological findings from two Parkinson’s disease patients after intraputaminal GDNF infusion

    T.R. Yamasaki, V.D. Smith, Y. Ai, D.M. Gash, P.T. Nelson, G.A. Gerhardt, J.T. Slevin (Lexington, KY, USA)

    Objective: To describe the postmortem findings from two patients who underwent intraputaminal infusion of glial-derived neurotrophic factor (GDNF). Background: GDNF has been shown to have…
  • 2016 International Congress

    Effects of the biodex stability system training on balance, gait and fatigue in Parkinson’s disease

    G. Singh, R. Pahwa, K.E. Lyons, Y. Colgrove, N.K. Sharma (Troy, NY, USA)

    Objective: The purpose of this study was to evaluate the effects of 4 weeks of BSS training on balance, gait and fatigue in PD patients.…
  • 2016 International Congress

    A healthy volunteer phase 1 study of RE-024, a potential phosphopantothenate replacement therapy for patients with pantothenate kinase-associated neurodegeneration (PKAN)

    R.D. Marshall, A. Harring-Abbott, K. Lucey, K. Leach, M. Beconi, J. Hunt, H. Plotkin (San Diego, CA, USA)

    Objective: To assess the safety, tolerability, and pharmacokinetics of single oral doses of RE-024 in healthy adult volunteers. Background: PKAN is a rare, autosomal recessive,…
  • 2016 International Congress

    Objectivisation of postural disorders in patients with Parkinson’s disease during the screening stage for DBS

    A.G. Buniak, I.P. Maryenko, S.A. Likhachev (Minsk, Belarus)

    Objective: Objectivisation of degree of postural disorders in PD patients during the screening stage for DBS. Background: The neurosurgical treatment of Parkinson's disease (PD) using…
  • « Previous Page
  • 1
  • …
  • 371
  • 372
  • 373
  • 374
  • 375
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley